Mechanism of the protective effect of heteropolyoxotungstate against herpes simplex virus type 2

被引:17
作者
Dan, K
Miyashita, K
Seto, Y
Fujita, H
Yamase, T
机构
[1] Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, Tokyo 160, Japan
[2] Tokyo Inst Technol, Resources Utilizat Res Lab, Yokohama, Kanagawa 227, Japan
关键词
anti-herpes simplex virus activity; herpes simplex attachment; polymerase chain reaction; penetration; polyoxotungstate; second-round infection;
D O I
10.1159/000067738
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of heteropolyoxotungstate (K-7[PTi2W10O40]. 6H(2)O; PM-19) on the replication of herpes simplex virus type 2 (HSV-2) were examined using a semiquantitative polymerase chain reaction of intracellular viral DNA established by us and also other methods. Vero cells were infected with HSV-2 strains: either the standard strain 169, or the acyclovir-resistant strain YS-4C-1. PM-19 was added at various stages during the replication of HSV-2. PM-19 strongly inhibited the synthesis of viral genomic DNA when it was added at the time of infection. The addition of PM-19 60-90 min after viral inoculation time-dependently decreased the antiviral activity and increased the relative yield of viral DNA, and the addition of PM-19 was completely ineffective at times later than 90 min. These results suggested that PM-19 inhibited viral penetration but did not affect the synthesis of viral DNA. Furthermore, PM-19 strongly inhibited a second round of infection. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 27 条
[1]   Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC (nectin-1) with different affinities [J].
Connolly, SA ;
Whitbeck, JC ;
Rux, AH ;
Krummenacher, C ;
Littel-van den Hurk, SV ;
Cohen, GH ;
Eisenberg, RJ .
VIROLOGY, 2001, 280 (01) :7-18
[2]   Quantitation of herpes simplex viral DNA in vero cells for evaluation of an antiviral agent using the polymerase chain reaction [J].
Dan, K ;
Miyashita, K ;
Seto, Y ;
Yamase, T .
JOURNAL OF VIROLOGICAL METHODS, 1998, 76 (1-2) :73-79
[3]  
DAN K, 1990, JPN J PHARM S, V52, P168
[4]   ANTITUMOR-ACTIVITY OF NEW ANTITUMOR SUBSTANCE, POLYOXOMOLYBDATE, AGAINST SEVERAL HUMAN CANCERS IN ATHYMIC NUDE-MICE [J].
FUJITA, H ;
FUJITA, T ;
SAKURAI, T ;
YAMASE, T ;
SETO, Y .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 168 (02) :421-426
[5]   INVITRO ANTIVIRAL ACTIVITY OF POLYOXOTUNGSTATE (PM-19) AND OTHER POLYOXOMETALATES AGAINST HERPES-SIMPLEX VIRUS [J].
FUKUMA, M ;
SETO, Y ;
YAMASE, T .
ANTIVIRAL RESEARCH, 1991, 16 (04) :327-339
[6]  
FUKUMA M, 1989, JPN J PHARM S, V49, P72
[7]   Real time quantitative PCR [J].
Heid, CA ;
Stevens, J ;
Livak, KJ ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :986-994
[8]   ANTI-HIV-1 ACTIVITY, TOXICITY, AND STABILITY STUDIES OF REPRESENTATIVE STRUCTURAL FAMILIES OF POLYOXOMETALATES [J].
HILL, CL ;
WEEKS, MS ;
SCHINAZI, RF .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) :2767-2772
[9]  
INOUYE Y, 1991, CHEM PHARM BULL, V39, P1638
[10]  
INOUYE Y, 1990, CHEM PHARM BULL, V38, P285